X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (47) 47
breast cancer (32) 32
index medicus (32) 32
humans (29) 29
female (28) 28
chemotherapy (15) 15
breast neoplasms - pathology (14) 14
cancer (14) 14
middle aged (13) 13
prognosis (13) 13
aged (12) 12
adult (9) 9
care and treatment (9) 9
survival (9) 9
breast neoplasms - genetics (8) 8
medicine & public health (8) 8
breast neoplasms - metabolism (7) 7
her2 (7) 7
obstetrics & gynecology (7) 7
trastuzumab (7) 7
aged, 80 and over (6) 6
breast neoplasms - drug therapy (6) 6
breast neoplasms - therapy (6) 6
hematology, oncology and palliative medicine (6) 6
immunohistochemistry (6) 6
lymphocytes (6) 6
metastasis (6) 6
neoadjuvant therapy (6) 6
neoplasm staging (6) 6
research (6) 6
tumors (6) 6
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
biomarkers (5) 5
cancer patients (5) 5
estrogen (5) 5
neoadjuvant chemotherapy (5) 5
receptor, erbb-2 - metabolism (5) 5
therapy (5) 5
treatment outcome (5) 5
trial (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
brain metastases (4) 4
docetaxel (4) 4
endocrine therapy (4) 4
metastatic breast cancer (4) 4
multivariate analysis (4) 4
pathological complete response (4) 4
patient outcomes (4) 4
randomized-trial (4) 4
receptors, estrogen - metabolism (4) 4
retrospective studies (4) 4
triple negative breast neoplasms - pathology (4) 4
women (4) 4
biopsy (3) 3
breast neoplasms - immunology (3) 3
carboplatin (3) 3
carcinoma (3) 3
carcinoma, ductal, breast - drug therapy (3) 3
carcinoma, lobular - pathology (3) 3
combined modality therapy (3) 3
distant recurrence (3) 3
early breast cancer (3) 3
estrogen receptor (3) 3
estrogen-receptor (3) 3
follow-up (3) 3
gene expression regulation, neoplastic (3) 3
genetic aspects (3) 3
internal medicine (3) 3
lymphocytes, tumor-infiltrating - pathology (3) 3
mutation (3) 3
open-label (3) 3
paclitaxel (3) 3
pathology (3) 3
phase-ii trial (3) 3
phase-iii trial (3) 3
relapse (3) 3
studies (3) 3
surgical oncology (3) 3
survival rate (3) 3
tamoxifen (3) 3
triple negative breast neoplasms - drug therapy (3) 3
tumor-infiltrating lymphocytes (3) 3
1st-line treatment (2) 2
adenocarcinoma - pathology (2) 2
adjuvant chemotherapy (2) 2
adjuvant trastuzumab (2) 2
adjuvant treatment (2) 2
american-society (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
animals (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
bc (2) 2
bibf 1120 (2) 2
biomarkers, tumor - analysis (2) 2
body-mass index (2) 2
brain neoplasms - secondary (2) 2
brain neoplasms - therapy (2) 2
breast neoplasms - diagnosis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Opinion in Oncology, ISSN 1040-8746, 01/2019, Volume 31, Issue 1, pp. 35 - 42
PURPOSE OF REVIEWCurrent standard for HER2+ early breast cancer patients includes chemotherapy and trastuzumab for 1 year. The purpose of this article is to... 
CARDIAC SAFETY | MULTICENTER | FINAL ANALYSIS | breast cancer | FOLLOW-UP | dual blockade | OPEN-LABEL | PLUS TRASTUZUMAB | ADJUVANT TRASTUZUMAB | FREE CHEMOTHERAPY REGIMENS | SINGLE-GROUP | ONCOLOGY | de-escalation | HER2 | NEOADJUVANT PERTUZUMAB | Care and treatment | Breast cancer | Genetic aspects | Research
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2019, Volume 37, Issue 7, pp. 559 - 569
PurposeThe aim of the current study was to conduct a pooled analysis of studies that have investigated the prognostic value of tumor-infiltrating lymphocytes... 
TRIAL | TILS | ONCOLOGY | DOCETAXEL | CHEMOTHERAPY
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2019
Identification of HER2-positive breast cancers with high anti-HER2 sensitivity could help de-escalate chemotherapy. Here, we tested a clinically applicable... 
Journal Article
Journal of Palliative Medicine, ISSN 1096-6218, 06/2019, Volume 22, Issue 6, pp. 691 - 695
Background: Neoplastic pericardial effusion (NPE) is a life-threatening condition that can worsen clinical outcome in cancer patients. The optimal management... 
Brief Reports | locoregional treatment | prognostic factors | systemic treatment | neoplastic pericardial effusion
Journal Article
The Oncologist, ISSN 1083-7159, 11/2018, Volume 23, Issue 11, pp. 1289 - 1299
This article presents data regarding patient characteristics, treatment patterns, and prognostic factors from a contemporary cohort of 153 patients with breast... 
Leptomeningeal disease | Human epidermal growth receptor 2 | Breast cancer | Prognosis | Treatment | SURVIVAL | SINGLE-CENTER EXPERIENCE | CLINICAL-FEATURES | CEREBROSPINAL-FLUID | CHEMOTHERAPY | LAPATINIB | IMPACT | MENINGEAL CARCINOMATOSIS | ONCOLOGY | DISEASE | BRAIN METASTASES
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 435 - 435
Journal Article
Anticancer Research, ISSN 0250-7005, 07/2017, Volume 37, Issue 7, pp. 3723 - 3728
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 9/2015, Volume 7, Issue 3, pp. 161 - 169
The phosphoinositide 3 kinase (PI3K)/Akt pathway is frequently aberrantly activated in breast cancer and, basing on preclinical data, leads to cell growth and... 
Medicine & Public Health | PIK3CA | PI3K | Oncology | Internal Medicine | Breast cancer | Predictive factor | Surgical Oncology | Estrogen
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 06/2012, Volume 65, Issue 6, p. 503
BackgroundThe incidence of autism rose dramatically between 1992 and 2001, while the age at which children were first diagnosed declined. During this period... 
Journal Article
PLoS Medicine, ISSN 1549-1277, 12/2016, Volume 13, Issue 12, pp. e1002201 - e1002201
Journal Article